Exogenous Ketone Supplementation and Exercise Performance
The Effect of Exogenous Ketone Supplementation on 20 km Time Trial and Wingate Performance in Recreationally Active Individuals
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Manuel D Quinones, MSc
- Phone Number: 88164 5196612111
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 3K7
- Recruiting
- Exercise Nutrition Laboratory (Western University)
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy male and female recreationally active individuals
- aged 15-35 years
- non regular caffeine users.
Exclusion Criteria:
- Smoker
- Taking part in other research
- Sedentary
- For women, if they are pregnant or become pregnant during the study
- Injury limiting exercise ability.
- Have symptoms or take medication for respiratory disease
- Have symptoms or take medication for cardiovascular disease
- Have symptoms or take mediation for neuromuscular disease
- Use heart rate or blood pressure medications
- Use any medications with side effects of dizziness, lack of motor control, or slowed reaction time
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Water Placebo
Placebo flavored drink similar to treatments but with no energy will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test
|
20 km time trial cycling test will be conducted to measure the effect of different drinks on time
30 second all-out effort on a bike will be conducted to measure the effect of different drinks on peak power output
Dietary supplement containing only water
|
|
Experimental: Experimental 1
Ketone salts supplement mixed in water will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test
|
20 km time trial cycling test will be conducted to measure the effect of different drinks on time
30 second all-out effort on a bike will be conducted to measure the effect of different drinks on peak power output
Dietary supplement containing only ketone salts
|
|
Experimental: Experimental 2
Ketone salts/caffeine supplement mixed in water will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test
|
20 km time trial cycling test will be conducted to measure the effect of different drinks on time
30 second all-out effort on a bike will be conducted to measure the effect of different drinks on peak power output
Dietary supplement containing ketone salts and caffeine
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
20 km time trial
Time Frame: 40 minutes
|
participants will ride for 20 km on a stationary bike and time to complete distance will be measured.
|
40 minutes
|
|
Wingate test
Time Frame: 30 seconds
|
participants will perform a ver short all-out effort on a stationary bike.
peak power output and fatigue index will be measured.
|
30 seconds
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Ketone
Time Frame: 1 hour
|
blood ketones will be measured using ketone meter
|
1 hour
|
|
Blood Lactate
Time Frame: 1 hour
|
blood lactate will be measured using lactate meter
|
1 hour
|
|
Rates of perceived exertion (RPE)
Time Frame: 1 hour
|
RPE will be measured using Borg's scale (1= low - 10= high).
|
1 hour
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Metabolic Diseases
- Acid-Base Imbalance
- Acidosis
- Ketosis
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Purinergic Antagonists
- Purinergic Agents
- Phosphodiesterase Inhibitors
- Purinergic P1 Receptor Antagonists
- Central Nervous System Stimulants
- Caffeine
Other Study ID Numbers
Other Study ID Numbers
- 113474
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.